Fournier-Majoie is a venture capital fund that supports early-stage health and biotech companies, particularly those focused on improving cancer treatment. Founded in December 2006 as a non-profit, the fund identifies, supports, and guides promising researchers. Their goal is to advance tools for early cancer detection and better treatment options. They have invested in companies such as HEPHAISTOS-Pharma.
